On the elimination of 5-hydroxyindoleacetic acid and homovanillic acid from cerebrospinal fluid.
D000818:Animals; D001565:Benzoates / Q000494:pharmacology; D001593:Benzyl Compounds / Q000494:pharmacology; D001693:Biological Transport, Active / Q000187:drug effects; D001812:Blood-Brain Barrier; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D001933:Brain Stem / Q000378:metabolism; D002421:Caudate Nucleus / Q000378:metabolism; D004285:Dogs; D004298:Dopamine / Q000134:cerebrospinal fluid; D006207:Half-Life; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D009638:Norepinephrine / Q000134:cerebrospinal fluid; D010648:Phenylacetates / Q000134:cerebrospinal fluid*; D011339:Probenecid / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012701:Serotonin / Q000134:cerebrospinal fluid; D013045:Species Specificity; D013449:Sulfonamides / Q000494:pharmacology*; D013997:Time Factors; D015049:Zoxazolamine / Q000494:pharmacology*
D001565:Benzoates; D001593:Benzyl Compounds; D010648:Phenylacetates; D013449:Sulfonamides; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D015049:Zoxazolamine; D011339:Probenecid; D004298:Dopamine; D009638:Norepinephrine; D006719:Homovanillic Acid